Invention Grant
- Patent Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
-
Application No.: US15030779Application Date: 2014-10-30
-
Publication No.: US09649294B2Publication Date: 2017-05-16
- Inventor: Songnian Lin , Libo Xu , Emma R. Parmee , Xibin Liao
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cocuzzo; Catherine D. Fitch
- International Application: PCT/US2014/063021 WO 20141030
- International Announcement: WO2015/066252 WO 20150507
- Main IPC: A61K31/404
- IPC: A61K31/404 ; C07D209/18 ; A61K45/06 ; A61K31/397 ; A61K31/4035 ; C07D209/20
Abstract:
Glucagon receptor antagonist compounds are disclosed which are of long duration of action. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US20160250184A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Public/Granted day:2016-09-01
Information query
IPC分类:
